Now Andropeyronie®, PRP and surgery are the unique options to treat Peyronie’s disease in Europe, Asia and Australia. Andromedical announces that now the only methods available in these continents to treat Peyronie’s disease are the penile traction device...
Peyronie’s disease (PD) is an accumulation of collagen in the penis that forms a scar, producing a deformity and pain in the erectile state. This disease affects between 1%-8% of men. The ANDROMEDICAL laboratory announces the great potential of a new combined...
A recent study by the American Urological Association, led by Dr. Pastuszak of the University of Utah School of Medicine (USA) showed that the Andropeyronie brand of Andromedical penile traction device is one of the 3 most used words in tweets about Peyronie’s...
A new medical protocol to treat the Peyronie’ disease was developed based on the clinical study published in Journal of Sexual Medicine, May-2019, The use of a penile traction device reduces the need of cycles of collagenase in patients with Peyronie’...
New York, US– 12.02.2019 A special medical research appointed by Andromedical (andromedical.com) shows Intense Phase Peyronie’s Condition can be successfully handled with a Traction Tool in a Non-randomized Possible Regulated Test, with Ultrasound...
Urological Organizations advise combining the remodeling technique of Andromedical based on Penile Traction Therapy with Collagenase injections to treat Peyronie’s condition. Andromedical Lab has patented as well as researched Penile Traction Devices for two...
